220 related articles for article (PubMed ID: 22737706)
1. Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children.
Katsunuma T; Ohya Y; Fujisawa T; Akashi K; Imamura N; Ebisawa M; Daikoku K; Kondo N; Terada A; Doi S; Nishimuta T; Noma T; Hamasaki Y; Kurihara K; Masuda K; Yamada T; Yamada M; Yoshihara S; Watanabe K; Watanabe T; Kitabayashi T; Morikawa A; Nishima S;
Allergy Asthma Proc; 2012; 33(3):e28-34. PubMed ID: 22737706
[TBL] [Abstract][Full Text] [Related]
2. Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children.
Katsunuma T; Ohya Y; Fujisawa T; Akashi K; Imamura N; Ebisawa M; Daikoku K; Kondo N; Terada A; Doi S; Nishimuta T; Noma T; Hamasaki Y; Kurihara K; Masuda K; Yamada T; Yamada M; Yoshihara S; Watanabe K; Watanabe T; Kitabayashi T; Morikawa A; Nishima S
Allergy Asthma Proc; 2012 May; 33(3):28-34. PubMed ID: 29165196
[TBL] [Abstract][Full Text] [Related]
3. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
Lin Q; Liu QH; Bao YX
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
[TBL] [Abstract][Full Text] [Related]
5. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
[TBL] [Abstract][Full Text] [Related]
6. A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
Inoue H; Niimi A; Matsumoto H; Ito I; Oguma T; Otsuka K; Takeda T; Nakaji H; Tajiri T; Iwata T; Nagasaki T; Mishima M
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):21-29. PubMed ID: 27718262
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
[TBL] [Abstract][Full Text] [Related]
8. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
Hozawa S; Haruta Y; Terada M; Yamakido M
Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
[TBL] [Abstract][Full Text] [Related]
10. Tulobuterol in childhood asthma: single dose ranging and repeated oral dose comparative studies.
Javier MA; Noche ML
J Int Med Res; 1986; 14(5):228-35. PubMed ID: 2876923
[TBL] [Abstract][Full Text] [Related]
11. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.
Yoshihara S; Yamada Y; Abe T; Arisaka O
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):879-80. PubMed ID: 16802779
[No Abstract] [Full Text] [Related]
12. [The efficacy and safety of tulobuterol tape in mild and moderate persistent asthma patients].
Su N; Lin JT; Yang M; Chen X; He J; He QY; Cao ZL; Chen BY; Xiao Y; Yan XX
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):39-42. PubMed ID: 17331388
[TBL] [Abstract][Full Text] [Related]
13. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function.
Kume H; Kondo M; Ito Y; Suzuki R; Yamaki K; Takagi K
Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1076-83. PubMed ID: 12390295
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
[TBL] [Abstract][Full Text] [Related]
15. Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Mochizuki H; Nanjo Y; Takahashi H
Geriatr Gerontol Int; 2013 Apr; 13(2):398-404. PubMed ID: 22817699
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy.
Burioka N; Miyata M; Endo M; Fukuoka Y; Suyama H; Nakazaki H; Igawa K; Shimizu E
Chronobiol Int; 2005; 22(2):383-90. PubMed ID: 16021849
[TBL] [Abstract][Full Text] [Related]
17. Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler in children with mild to moderate asthma.
Ståhl E; Ribeiro LB; Sandahl G
Pediatr Pulmonol; 1996 Aug; 22(2):106-10. PubMed ID: 8875584
[TBL] [Abstract][Full Text] [Related]
18. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Kobayashi Y; Yasuba H; Kudou M; Kita H
J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
Kanehara M; Yokoyama A; Tomoda Y; Shiota N; Iwamoto H; Ishikawa N; Taooka Y; Haruta Y; Hattori N; Kohno N
Pulm Pharmacol Ther; 2008 Dec; 21(6):874-8. PubMed ID: 18983928
[TBL] [Abstract][Full Text] [Related]
20. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
Fujimori K; Suzuki E; Gejyo F
Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
